Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doors
- 15 September 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 32 (6) , 463-471
Abstract
Purpose of review: Systemic sclerosis (SSc) is a severe rheumatic disease characterized by a considerable heterogeneity in clinical presentations and pathophysiological mechanisms. This variability has a substantial impact on morbidity and mortality and limits the generalizability of clinical trial results. This review aims to highlight recent studies that have proposed new innovative approaches to decipher this heterogeneity, in particular, by attempting to optimize disease classification. Recent findings: The historical dichotomy limited/diffuse subsets based on cutaneous involvement has been challenged by studies highlighting an underestimated heterogeneity between these two subtypes and showing that presence of organ damage and autoantibody profiles markedly influenced survival beyond skin extension. Advanced computational methods using unsupervised machine learning analyses of clinical variables and/or high-throughput omics technologies, clinical variables trajectories modelling overtime or radiomics have provided significant insights on key pathogenic processes that could help defining new subgroups beyond the diffuse/limited subsets. Summary: We can anticipate that a future classification of SSc patients will integrate innovative approaches encompassing clinical phenotypes, variables trajectories, serological features and innovative omics molecular signatures. It nevertheless seems crucial to also pursue the implementation and standardization of readily available and easy to use tools that can be used in clinical practice.Keywords
This publication has 48 references indexed in Scilit:
- A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective studyAnnals of the Rheumatic Diseases, 2016
- Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosisAnnals of the Rheumatic Diseases, 2015
- Prediction of Pulmonary Complications and Long‐Term Survival in Systemic SclerosisArthritis & Rheumatology, 2014
- Systemic sclerosis: beyond limited and diffuse subsets?Nature Reviews Rheumatology, 2014
- Molecular Signatures in Skin Associated with Clinical Improvement during Mycophenolate Treatment in Systemic SclerosisJournal of Investigative Dermatology, 2013
- Intrinsic Gene Expression Subsets of Diffuse Cutaneous Systemic Sclerosis Are Stable in Serial Skin BiopsiesJournal of Investigative Dermatology, 2012
- Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research GroupAnnals of the Rheumatic Diseases, 2011
- Molecular Subsets in the Gene Expression Signatures of Scleroderma SkinPLOS ONE, 2008
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- Progressive Systemic Sclerosis Sine SclerodermaJAMA, 1962